Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-12-22 00:00:00 ET · period of report 2023-12-21 · accession 0001048477-23-000064 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-22 | 2023-12-21 | BMRN | BIENAIME JEAN JACQUES | Dir | M - OptEx | $63.10 | +10.0K | 435.1K | +2% | +$631.0K |
| D | 2023-12-22 | 2023-12-21 | BMRN | BIENAIME JEAN JACQUES | Dir | S - Sale+OE | $93.99 | -10.0K | 425.1K | -2% | -$939.9K |
| D | 2023-12-22 | 2023-12-21 | BMRN | BIENAIME JEAN JACQUES | Dir | M - OptEx | $0.00 | -10.0K | 181.0K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-21 | M | A | 10,000 | $63.10 | 435,112 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on August 7, 2023. |
| 2 | Common | Common Stock | 2023-12-21 | S | D | 10,000 | $93.99 | 425,112 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on August 7, 2023. |
| 3 | Derivative | Stock Option (Right to Buy Common Stock) | 2023-12-21 | M | D | 10,000 | $0.00 | 181,000 | D | $63.10 · 2014-12-04 to 2024-06-03 | 10,000 Common Stock | (F2) Reflects the number of options outstanding after the transactions from this specific stock option grant. |